Motus GI Holdings (STU:7M4) Beta: -0.9330 (As of Jun. 27, 2026)


STU:7M4 Motus GI Holdings Inc STU:7M4
12 GF Score
Price €6.36
View Full Analysis

What is Motus GI Holdings Beta?

Motus GI Holdings STU:7M4 12 Beta is -0.9330 as of Jun. 27, 2026. GuruFocus rates STU:7M4 with a GF Score™ of 12/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), Motus GI Holdings's Beta is -0.9330.


Motus GI Holdings  (STU:7M4) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Motus GI Holdings Beta Related Terms


Motus GI Holdings Beta Historical Data

* Premium members only.

The historical data trend for Motus GI Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Motus GI Holdings Beta Chart

Motus GI Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 -0.53

Motus GI Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 0.59 0.56 -0.53 -0.37

STU:7M4 vs ABT, BSX, SYK: Beta Comparison

For the Medical Devices subindustry, Motus GI Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Motus GI Holdings Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's Beta falls into.


STU:7M4
12GF Score
Motus GI Holdings Inc STU:7M4
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Motus GI Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.9330 mean?
Motus GI Holdings (STU:7M4) has a Beta of -0.9330 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Motus GI Holdings and its competitors.
Is Motus GI Holdings' Beta too high?
Motus GI Holdings' current Beta is -0.9330. Overall, Motus GI Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Motus GI Holdings' Beta compare to ABT and BSX?
Motus GI Holdings' Beta of -0.9330 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Motus GI Holdings and its competitors. Motus GI Holdings's current Beta is -0.9330. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Motus GI Holdings stock overvalued right now?
Motus GI Holdings (STU:7M4) has a current Beta of -0.9330. The current Beta is -0.9330. Motus GI Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Motus GI Holdings (STU:7M4), the current Beta is -0.9330 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Motus GI Holdings Business Description

Address 1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs, and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
12GF Score

Get the complete analysis for STU:7M4

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.36
Price